CARDILE, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 2.161
NA - Nord America 1.564
AS - Asia 1.156
SA - Sud America 300
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 47
OC - Oceania 2
Totale 5.289
Nazione #
US - Stati Uniti d'America 1.514
RU - Federazione Russa 1.233
SG - Singapore 402
CN - Cina 312
BR - Brasile 251
IT - Italia 203
IE - Irlanda 198
SE - Svezia 169
VN - Vietnam 154
HK - Hong Kong 90
DE - Germania 85
FR - Francia 57
BD - Bangladesh 56
FI - Finlandia 52
GB - Regno Unito 49
IN - India 42
AT - Austria 29
PL - Polonia 28
CA - Canada 18
JP - Giappone 17
UG - Uganda 17
AR - Argentina 16
MX - Messico 13
CZ - Repubblica Ceca 11
ID - Indonesia 11
NL - Olanda 11
TR - Turchia 10
EC - Ecuador 9
IQ - Iraq 9
ZA - Sudafrica 9
ES - Italia 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
CO - Colombia 6
PK - Pakistan 6
UA - Ucraina 6
EG - Egitto 5
VE - Venezuela 5
CH - Svizzera 4
IR - Iran 4
JM - Giamaica 4
LB - Libano 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
CL - Cile 3
CR - Costa Rica 3
HN - Honduras 3
IL - Israele 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
DZ - Algeria 2
EU - Europa 2
GA - Gabon 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GY - Guiana 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MY - Malesia 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 5.234
Città #
Moscow 341
Singapore 235
Ashburn 205
Chandler 196
Dublin 196
San Jose 146
Dallas 137
Beijing 113
Nyköping 110
Dong Ket 98
Hong Kong 90
Council Bluffs 56
The Dalles 51
Los Angeles 47
Munich 46
New York 38
Catania 34
Jacksonville 28
Vienna 28
Princeton 27
Lauterbourg 25
Medford 24
São Paulo 24
Messina 23
Warsaw 23
Buffalo 22
Cambridge 21
Des Moines 19
Houston 18
Turku 18
Kampala 17
Lancaster 17
Dearborn 14
Ho Chi Minh City 14
Hyderabad 13
Milan 11
Phoenix 11
Shenyang 11
Brasília 10
Hanoi 10
Jinan 10
Kameido 10
Santa Clara 10
Boardman 9
London 9
Orem 9
Redondo Beach 9
Ann Arbor 8
Brno 8
Frankfurt am Main 8
Helsinki 8
Rome 8
Amsterdam 7
Bremen 7
Brooklyn 7
Denver 7
Eboli 7
Johannesburg 7
Mumbai 7
San Mateo 7
Shanghai 7
Wilmington 7
Atlanta 6
Brussels 6
Chicago 6
Fuzhou 6
Montreal 6
San Francisco 6
Stockholm 6
Taizhou 6
Tokyo 6
Ankara 5
Belo Horizonte 5
Hebei 5
Manchester 5
Mexico City 5
Pune 5
Shenzhen 5
Tianjin 5
Augusta 4
Baghdad 4
Caxias do Sul 4
Curitiba 4
Guangzhou 4
Haikou 4
Nanjing 4
Nuremberg 4
Pelotas 4
Poplar 4
Porto Alegre 4
Taiyuan 4
Toronto 4
Tübingen 4
Waverly Hall 4
Baku 3
Campinas 3
Changsha 3
Chennai 3
Las Vegas 3
Mislata 3
Totale 2.915
Nome #
111In-Pentetreotide for treatment of neuroendocrine tumours: an alternative therapeutic option in particular cases 244
111In-Pentetreotide in neuroendocrine tumours: comparison between diagnostic scintigraphy and “post-therapy” whole-body scan 235
111In-Pentetreotide therapy in patients with inoperable benign intracranial tumors. 223
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 205
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 187
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 185
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 174
A potentially misleading finding at somatostatin receptor scintigraphy: focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions 169
Is Detection of Additional Lesions in Post-Peptide ReceptorRadionuclide Therapy Scans With Respect to DiagnosticImaging Only Due to Different Affinity of Ligands?A Report of Discordance Between Diagnostic and Posttherapy Imaging Using the Same Ligand 152
Increased 177Lu-DOTATATE Uptake in Paget Disease 152
Exploring Consciousness Levels through Electrodermal Responses: A Pilot Study with Auditory Stimuli in DoC Patients 151
Meningocele mimicking a metastasis of papillary thyroid carcinoma 147
Long term follow-up of renal function in patients who underwent repeated peptide receptor radionuclide therapy 141
Paget disease revealed by Lu-177-DOTATATE post-therapy whole-body scan. 140
Demonstration of unknown primitive neuroendocrine tumor by post-treatment imaging with high activities of radiolabeled somatostatin analogues 135
Repeated administrations of peptide receptor radionuclide therapy: long term follow-up of renal function. 133
Our experience with peptide receptor radionuclide therapy in patients affected by pulmonary neuroendocrine tumors 131
Cognitive Effects of Transcranial Direct Current Stimulation Plus Robotic Verticalization in Minimally Conscious State 130
Calibration of a gamma camera for 177Lu quantitative imaging: measurements of sensitivity and scatter correction factors in broad beam geometry 130
Peptide receptor radionuclide therapy in patients with pulmonary neuroendocrine tumors: our experience 127
Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan 126
Febrile Urinary Tract Infections in Children: The Role of High Mobility Group Box-1 124
Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature 122
Post-therapy whole-body scan in patients who underwent peptide receptor radionuclide therapy using 111In-Pentetreotide reveals more lesions than diagnostic imaging with gamma emitters 114
Differences in the sensitivity of pretherapy and post-therapy scans in patients undergoing peptide receptor radionuclide therapy 113
Usefulness of 111In-pentetreotide therapy in patients with inoperable benign intracranial tumors 113
Challenges and pitfalls in the management of endocrine toxicities from immune checkpoint inhibitors: a case presentation of synchronous thyrotoxicosis and primary adrenal insufficiency in a melanoma patient 109
Renal function evaluation in patients undergoing repeated peptide receptor radionuclide therapy 109
Can artificial intelligence improve the diagnosis and prognosis of disorders of consciousness? A scoping review 107
Recent advances (2022–2024) in eye-tracking for Parkinson’s disease: a promising tool for diagnosing and monitoring symptoms 106
Gastroparesis in Adolescent Patient with Type 1 Diabetes: Severe Presentation of a Rare Pediatric Complication 106
Improving Neuroplasticity through Robotic Verticalization Training in Patients with Minimally Conscious State: A Retrospective Study 97
Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real Life Study 95
A systematic review on the use of virtual reality in post-stroke patients: exploring when modalities make the difference in executive and motor recovery 86
What about the Use of Ice Cream as a Supplementary Diet in Chronic Kidney Disease? A Case–Control Study 71
Role of Nutrition in the Etiopathogenesis and Prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in a Group of Obese Adults 70
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose 69
The Impact of Social Cognition Deficits on Quality of Life in Multiple Sclerosis: A Scoping Review 66
Sex Differences in Elderly Multiple Sclerosis Patients Undergoing Neurorehabilitation: How Many Things are Taken for Granted? A Retrospective Study 65
Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients 56
Low- and high-tech AAC approaches in severe acquired brain injury: an exploratory pilot study 51
null 16
Case Report: Tailored automatic speech recognition in global aphasia with dysarthria - a single case proof of concept 4
Neuropsychological assessment in adult epilepsy: rationale, test selection, and clinical integration across non-surgical care in Italian patients 3
Totale 5.289
Categoria #
all - tutte 16.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022158 0 0 3 7 8 1 18 7 3 33 16 62
2022/2023643 56 74 27 77 51 64 10 37 224 0 16 7
2023/2024160 7 16 9 20 11 47 1 2 1 15 5 26
2024/2025733 13 5 3 50 31 37 30 114 156 68 96 130
2025/20262.871 162 122 170 166 261 565 318 388 377 156 94 92
2026/2027236 100 121 15 0 0 0 0 0 0 0 0 0
Totale 5.289